Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

684 IndexWWernicke–Korsakoff syndrome, 88, 94Wernicke’s encephalopathy, 87–88White Americansalcohol use and abuse, 323–324cocaine use and abuse, 185–186population statistics, 321smoking patterns, 117, 118Withdrawalalcohol, 86–87, 591–593assessment, 591benzodiazepines, 229–230, 231–232,236–238, 596cocaine, 191–192, 202cognitive capacity in, 42maintenance therapy rationale, 588–589neurobiology, 6–9, 10nicotine, 111, 589–591opioid, 597–600psychological assessment during, 42sedative/hypnotic drugs, 231Women, addictive disorders in, 437–438clinical features, 446–447epidemiology, 438–439health risks, 440prevention, 448–449psychological factors, 443–444reproductive functioning, 441risk factors, 439sociocultural factors, 444–445treatment, 447–448See also Gender differencesWorkplaceathletes, special problems of, 348detecting substance use, 68, 69–71,223, 342–343, 346Xdisability claims, 360drug-free workplace programrequirements, 69–70drug-specific manifestations, 343–345health care settings, 349–350high-responsibility occupations, 350–351historical development of interventionin, 30–31legal issues regarding testing andtreatment, 341mandated reporting of drug use, 350–351negative outcomes of substance use in,340–341organizational factors in substancemisuse, 342, 345–346patterns and prevalence of substanceuse, 341police and military personnel, 351–352practice issues, 340, 345preemployment interview, 342–343,345psychological assessment in, 55substance-abusing executives, 348, 349treatment and interventions, 345–348Xanax, 237–238ZZaleplon, 238–239Zolpidem, 238–239